An Hendrix, assistant professor, is cancer researcher at Ghent University and the Cancer Research Institute Ghent (CRIG) (https://www.crig.ugent.be/en/prof-an-hendrix-phd). Her team studies small Rab GTPase-mediated release of extracellular vesicles (EV) by tumors, and the isolation and characterization of these nanometer-sized vesicles from liquid biopsies (published in highly ranked journals such as Nature Methods, Gut, JNCI, Cancer Research and Journal of Extracellular Vesicles). As such her team aims to get a deeper insight into the relevant aspects of EV and their biogenesis, and to exploit them for precision oncology. To allow and boost the clinical implementation of EV in daily clinical practice An Hendrix significantly invested in standardization and reproducibility of EV research since this is the foremost important step to initiate biomarker discovery in any type of biofluid for any type of disease. An Hendrix was awarded with a CRIG young investigator proof of concept grant (2017) and the prize of Medical Research 2010-2013 by the Belgian Royal Academies of Medicine (2013). She yearly organizes the EMBO/EMBL practical course on extracellular vesicles (Heidelberg, Germany: https://www.embl.de/training/events/2019/EXO19-01/). An Hendrix contributed to The Massive Online Open Course “Basics of Extracellular Vesicles”. She is founder of the EV-TRACK consortium that aims to increase transparent reporting and reproducibility in EV research (www.evtrack.org) and of the Belgian Society for Extracellular Vesicles that connects Belgian scientists working on EV (www.besev.be).